two functionally different cell populations, which has important implications for the interpretation of previously generated data using this kit to characterize CD1c + cDCs.
Introduction
The cells of the mononuclear phagocyte system are subdivided into dendritic cells (DCs), monocytes and macrophages. Among these, DCs are the most adept at promoting naïve T cell activation. Plasmacytoid and conventional (c) DCs are specialized subsets identified by expression of distinct surface markers [1] . cDCs comprise two subsets: Blood CD1c + DCs are SIRPα + and assigned to the cDC2 lineage, as opposed to SIRPα -CD141 + DNGR1 + cDCs that constitute the cDC1 lineage [2] . CD1c + DCs are the major subset of DCs among human peripheral blood mononuclear cells (PBMCs) [1, 3] and in a variety of human tissues [4] [5] [6] [7] [8] . CD1c + DCs have been found to efficiently induce naïve CD4 + T cells [3, 4] . The antigen CD1c (BDCA-1) is a member of the CD1 family of transmembrane glycoproteins which are structurally related to major histocompatibility complex (MHC) proteins. CD1 proteins mediate presentation of lipid and glycolipid antigens, including mycobacterial cell wall components, to T cells [9] . cDCs constitute only a small fraction of blood and tissue cells, rendering enrichment and isolation techniques favorable. CD1c + DCs were early on defined as negative for lineage (lin) markers (CD3, CD16, CD19, CD20, CD56) and for CD141 (BDCA-3), as well as the plasmacytoid DC markers CD303 (BDCA2) and CD304 (BDCA-4), with a minor proportion expressing CD14 [1] . This definition is presently used as basis for the application of a commercially available CD1c (BDCA-1) + Dendritic Cell Isolation Kit (Miltenyi Biotec), suggesting that after the removal of CD19 + B cells, only CD1c + cDCs are positively selected from the remaining cell suspension using CD1c-targeting antibody [10] . However, here we report that CD1c is expressed by a fraction of human monocytes in blood and mucosal tissues, and demonstrate that this widely-used kit isolates CD1c + cell populations that show striking phenotypical and functional differences.
Materials and Methods

Samples
Blood samples were obtained from healthy adult blood donors at Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway. Citrate phosphate dextrose solution was used as anticoagulant. Peripheral blood mononuclear cells (PBMCs) were isolated by Lymphoprep™ (Stemcell technologies, Vancouver, Canada) density gradient centrifugation. Mucosal tissue samples from the distal duodenum / proximal jejunum were obtained during Whipple procedure on pancreatic cancer patients, distant from the tumor. The tissue was immediately transported to our laboratory and prepared for immunohistochemistry (see below) and for flow cytometry. In the latter situation epithelial cells were removed by three washing steps with 2mM EDTA in PBS for 20min at 37°C. The remaining lamina propria was digested in RPMI containing 0.25mg/ml liberase (Roche, Mannheim, Germany) and 20U/ml DNase I (Roche) at 37°C. Mononuclear cells were enriched by Lymphoprep™ (Stemcell technologies) density gradient centrifugation.
Samples of nasal mucosa were obtained from the lower edge of the inferior turbinate during surgery for septum deviation on healthy donors (n = 7), or donors with grass or birch allergy out of season (n = 4). The tissue was finely minced and digested as above.
Samples of bronchial mucosa were obtained from patients with non-small cell lung cancer (n = 5). The lung lobe was removed and mucosa was scraped off from inside the largest bronchus distant to the tumor region. The tissue was finely minced and digested as above.
All participants provided written consent, and the study was approved by the Norwegian Regional Committee for Medical Research Ethics (Oslo, Norway).
Flow Cytometry and antibodies
CD19-PE-Cy7 (HIB19), CD14-APC-Cy7 (HCD14), CD45-v510 (HI30), HLA-DR-bv605 (L243), CD1c-PerCP, -PE, -APC (all L161), SIRPα-PE-Cy7 (SE5A5), CD1a-PE (HI149), CD16-PE (3G8), DNGR1-PE (8F9), CD115-PE (9-4D2-1EA), CCR2-bv421 (MCP1), CD11b-bv421 (ICRF44) and TREM1-PE (TREM-26) were from Biolegend (San Diego, CA). CD103-FITC, -PE and -APC (all B-Ly7) were from eBioscience (San Diego, CA). CD3-APC (sk7), CD20-PE (L27), CD56-PE (B159), CD11c-APC, -PE (both s-HCL-3) and CD11c-v450 (B-Ly6) were from BD Bioscience (San Jose, CD). Calprotectin-PE (MAC387; targeting subunit S100A9) was from AbD Serotec (Oxfordshire, United Kingdom). PD-L1-APC (PDL1.3.1) and CD207 (DCGM4) were from Beckman Coulter (Fullerton, CA). For staining procedures of intracellular proteins, cells were permeabilized using the FoxP3 / transcription factor staining buffer set according to the manufacturer's instructions (eBioscience 
CD14
+ monocytes were then sorted on a BD ARIAIIu (BD). To this end we used the antibodies CD45-APC-Cy7 (H130), HLA-DR-PerCP-Cy5.5 (L243), CD14-PacificBlue (HCD14), SIRPα-PE-Cy7 (SE545) (all Biolegend) and CD11c-APC (S-HCL-3) (BD Bioscience). For generation of an enrichment protocol without the use of FACS-sorting, pre-depletion of monocytes was performed using CD14-MACS micro beads (Miltenyi Biotec) following the manufacturer's protocol.
Immunohistochemistry
Biopsies from small intestinal mucosa were mounted on a slice of carrot, using OCT compound (Tissue-Tek; Miles Laboratories, Elkhart, IN), then embedded in OCT compound, snap-frozen in liquid nitrogen, and stored at −p°C. 4 μm cryosections were cut and air-dried overnight at RT, post-fixed in acetone for 10 min, wrapped in aluminum foil, and stored at −20°C until used. Cryosections were incubated for 1 hour with anti-CD14 (clone 18D11, mIgG1, 1/500; Gift from Terje Espevik) and anti-CD1c (clone AD5-8E7, mIgG2, 1/10; Miltenyi Biotec), followed by Cy3-conjugated goat anti-mIgG1 (1/1500; Southern Biotech, Birmingham, AL) and alexa fluor 488-conjugated goat anti-mIgG2 (1/1000; Molecular Probes, Life Technologies) for 30 min. Sections incubated with the secondary antibodies alone were used as controls. Laser confocal microscopy was performed on an Olympus FV1000 (BX61WI) system (Olympus Corporation, Tokyo, Japan) with 60xLUMFI objective and 488nm, 543 and 633nm laser lines. Microscopy images were assembled in Photoshop CS4 and Illustrator CS6 (Adobe, San Jose, CA).
Mixed lymphocyte reaction
Naïve CD4 + T cells were isolated using the MACS Naïve CD4 + T cell isolation kit (miltenyi biotech), and stained with CFSE (Life Technologies) according to the manufacturer's instructions. APC subsets were pre-sorted on CD1c and FACS-sorted as described above, and equal numbers of cells (4,000-24,500) from each subset were cultured with naïve CFSE-stained CD4 + T cells at a ratio of 1:5 for 5-6 days in RPMI containing 10% heat-inactivated fetal calf serum, 1% penicillin-streptomycin and L-glutamine. As a control, equal amounts of T cells were cultured alone. For intracellular staining of cytokines, the co-cultures were stimulated with 25ng/ml PMA and 250ng/ml ionomycin for 3.5 h with addition of 10μg/ml brefeldin A. For CD4 + T cell phenotyping after co-culture experiments CD3-PE-Cy7 (UCH-T1), CD25-APC (2A4), T-bet-PE (o4-46) (all BD Bioscience), TNFα-bv605 (Mab11) and IL-10-bv421 (JES3-9D7) (both Biolegend) or matched isotype controls were used. For staining procedures of intracellular and nuclear proteins, cells were permeabilized using the FoxP3 / transcription factor staining buffer set according to the manufacturer's instructions (eBioscience).
Immunoassay
Supernatants from co-cultures were stored at -80°C until used. Cytokines were quantified using the Bio-Plex ProTM Human Treg Cytokine Panel (#171AL003M, Bio-Rad Laboratories, Hercules, CA) according to the manufacturers' instructions.
Statistics
Statistical analyses were performed using GraphPad Prism software (version 4; GraphPad Software, La Jolla, CA). A P value of less than 0.05 was considered significant. The tests used and magnitudes for P are indicated in each figure legend.
Results
Blood and mucosal tissue monocytes express CD1c
Numerous publications have used CD1c as a marker to isolate cDC2 cells from blood using a commercial bead-based isolation kit [11] [12] [13] [14] [15] [16] [17] [18] [19] . However, applying this kit we found that a substantial fraction of the positively sorted cells expressed high levels of CD14. This finding prompted us to investigate whether cDC2 cells purified using this kit were contaminated by monocytes. (Fig 1B) . Expression of CD1c was lower in both populations after culture (Fig 1B) . Growth factor receptor Fms-like tyrosine kinase 3 (Flt3) ligand-dependent development and therefore expression of Flt3 substantiates the identity of pre-cDC-derived cells [20] [21] [22] , contrasting the M-CSF-dependent development of monocyte-derived cells [23, 24] . Importantly, among the cultured cells isolated as CD1c + , CD14 + cells expressed high levels of the M-CSF-receptor CD115, whereas CD14 -cells expressed Flt3 (Fig 1C) . These data therefore clearly demonstrate that the isolated CD1c + population comprises both cDCs and monocytes. In addition to CD115, CD14 + CD1c + cells, but not CD14 -CD1c + , expressed further markers considered strongly and specifically expressed by blood monocytes: chemokine receptor CCR2 [25] , integrin alpha M (CD11b) [26] , triggering receptor expressed on myeloid cells TREM1 [27, 28] , as well as calprotectin subunit S100A9 [26, 29] (Fig 1C) .
To (Fig 2A, center panel) . CD115 + monocytes were uniformly SIRPα + and largely expressed CD1c, but at levels lower than DCs (Fig 2A, lower panel) . In order to determine whether CD1c expression is confined to a specific monocyte subset, we identified the three major blood monocyte populations based on their differential expression levels of CD14 (Fig 3A) , bronchial mucosa (Fig 3B) as well as small intestinal lamina propria (Fig 3C) [6, 19, [32] [33] [34] and CD207 [19, 35] is induced on blood-derived mononuclear phagocytes upon serum, GM-CSF and/or TGFβ-treatment and expressed on CD1c + DCs in tissues. We found that CD1a was up-regulated upon in vitro culture with addition of TGFβ, in both CD1c + DCs and CD1c + monocytes isolated from blood, while only DCs increased CD207 expression after TGFβ-treatment (Fig 4A) . Tissue CD1c + cDC2 also express PD-L1 [6, 36] and CD103 [4, 37, 38] , with CD103 reportedly induced by TGFβ-signaling [37] [38] [39] . PD-L1 was strongly induced in blood CD1c + DCs upon culture, whilst blood CD1c + monocytes consistently remained PD-L1 -. Blood CD1c + DCs also exhibited a strong up-regulation of CD103 independent of TGFβ, while CD1c + monocytes only displayed marginal increase of CD103 upon TGFβ treatment (Fig 4A) . This differential regulation of surface marker expression emphasizes the different properties of CD1c + DCs and CD1c + monocytes derived from blood. Next, we aimed to assess the response to TLR activation in blood-derived CD1c + cells.
Upon LPS stimulation, CD1c + monocytes exhibited a significantly greater induction of TNF expression as compared with CD1c + DCs, whereas levels of IL-10 and IL-12p40 production were increased after stimulation with LPS but comparable in both populations (Fig 4B) . Finally, in a mixed lymphocyte reaction, CD1c + DCs induced a significantly stronger proliferation of naïve CD4 + T cells and higher levels of IL-2 secretion compared with CD1c + monocytes (Fig 5A) . However, among the T cells that were stimulated by monocytes, a significantly higher fraction produced TNF after PMA/ionomcyin stimulation and expressed T-bet as + DCs and CD1c + monocytes in native blood, as well as of CD1c + isolated cells after culture ± 40ng/ml TGFβ for 48h. Data from 2-10 donors. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 (one-way RM-ANOVA). (B) Flow cytometric analysis of intracellular TNFα, IL-10 and IL-12p40 in CD1c + DCs and CD1c + monocytes isolated from blood upon stimulation with 1μg/ml LPS for 4.5h, 18h or 24h, respectively. Data from 3 donors. * P < 0.05, ** P < 0.01 (two-way RM-ANOVA).
doi:10.1371/journal.pone.0157387.g004 compared with T cells primed by DCs (Fig 5B) . This indicates a stronger skewing towards a proinflammatory Th1 response by CD1c + monocytes. Neither DCs nor monocytes induced considerable numbers of IL-10-producing T cells (Fig 5C and 5D ).
Monocyte pre-depletion increases of purity of CD1c + DCs (Fig 6) . + T cells isolated from human blood were cultured for 6d together with CD1c + DCs or CD1c + monocytes and proliferation and expression of CD25 were analyzed using flow cytometry. Cells are pre-gated on single, live CD3 + cells. IL-2 levels in the supernatant were assessed using Bio-Plex immune assay after 6 days of coculture. Data are derived from 4 experiments with different mononuclear phagocyte donors. * P < 0.05, *** P < 0.001 (t-test). (B) T-bet, TNFα and (C) IL-10 expression was assessed among proliferating CD25 + T cells after PMA/ionomycin stimulation (3 donors). * P < 0.05, ** P < 0.01 (t-test) (D) IL-10 concentrations in the supernatant were assessed using Bio-Plex immune assay after 6 days of coculture (4 donors). The horizontal dashed line represents the lowest concentration of the standard curve, data points below were extrapolated. [4, [40] [41] [42] [43] . Murine infection models indicate that monocytederived cells are important for the initiation of Th1 immunity [44] [45] [46] , and indeed the proliferating T cells induced by CD1c + monocytes were primarily T-bet + Th1 cells.
In our hands, the percentage of CD14 + monocytes among the bead-isolated CD1c + mononuclear phagocyte population showed great inter-individual variation, ranging from 25 to 70%. Accordingly, treating the CD1c + mononuclear phagocyte population as one entity will result in bias of the generated data depending on the donor-specific relative abundance of CD14 + CD1c + mononuclear phagocytes. Our results indicate that data-sets describing the expression of cell surface markers after culture [1, 13, 14] , cytokine secretion and responsiveness to stimulation [11] [12] [13] [14] [15] as well as T cell activation [13] [14] [15] Collectively, our findings demonstrate that CD1c is expressed by a subset of monocytes and contribute to a further dissection of the heterogeneity within the mononuclear phagocyte system. In addition, our results suggest that studies on CD1c + DCs isolated using CD1c-targeting alone need to be interpreted with caution.
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